Novo Nordisk CEO says innovation in obesity may justify higher price in some segments
Go back to Novo Nordisk CEO says innovation in obesity may justify higher price in some segments| NOVO-NORDISK A/S (NYSE: NVO) | Delayed: 47.42 +1.54 (3.36%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $45.88 | 52 Week High | $59.00 | |||
| Open | $46.80 | 52 Week Low | $32.80 | |||
| Day High | $47.43 | P/E | N/A | |||
| Day Low | $46.44 | EPS | $0.00 | |||
| Volume | 20,199,259 | |||||
